Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

IPIG 2025

2nd International PNH Interest Group (IPIG) Conference

15–16 May 2025 | Paris, France

The 2nd International PNH Interest Group (IPIG) Conference took place in Paris, France, on May 15-16, 2025. This meeting brought together leading experts in the field of PNH to share the latest research, advancements, and insights.

View all videos

Two-year results from the COMMODORE 2 trial of crovalimab in complement inhibitor-naïve PNH

Richard Kelly • 15 May 2025

Biomarkers in the era of complement inhibition for PNH

Austin Kulasekararaj • 15 May 2025

Investigating the relationship between hemoglobin, fatigue & quality of life in patients with PNH

Jens Panse • 15 May 2025

Unmet needs in the field of PNH

Benjamin Chin-Yee • 15 May 2025

COMMODORE 1 and 2 trials: breakthrough hemolysis events in PNH treated with crovalimab or eculizumab

Catherine Flynn • 15 May 2025

A Phase II trial of zaltenibart in patients with PNH with a suboptimal response to ravulizumab

Jens Panse • 15 May 2025

Preventing thrombosis in patients with PNH

Jeff Szer • 15 May 2025

Signs and symptoms that should prompt physicians to screen a patient for PNH

Jaroslav Čermák • 15 May 2025